ReviewScientifica2016
Assessing Risk in Patients with Stable Coronary Disease: When Should We Intensify Care and Follow-Up? Results from a Meta-Analysis of Observational Studies of the COURAGE and FAME Era.
Review in Scientifica, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 34 citations in OpenAlex.
- Machine learning-based prediction of composite risk of cardiovascular events in patients with stable angina pectoris combined with coronary heart disease: development and validation of a clinical prediction model for Chinese patients.Frontiers in pharmacology · 2023Article
- The Influence of Cardiovascular Risk Factors and Hypogonadism on Cardiac Outcomes in an Aging Population of Beta-Thalassemia Patients.Journal of cardiovascular development and disease · 2021Article
- Long term prognostic implication of newly detected abnormal glucose tolerance among patients with stable cardiovascular disease: a population-based cohort study.Journal of translational medicine · 2021Article
- Addition of routine blood biomarkers to TIMI risk score improves predictive performance of 1-year mortality in patients with ST-segment elevation myocardial infarction.BMC cardiovascular disorders · 2020Observational
- Factors associated with platelet reactivity during dual antiplatelet therapy in patients with diabetes after acute coronary syndrome.Scientific reports · 2020Article
- Does depressed persons with non-cardiovascular morbidity have a higher risk of CVD? A population-based cohort study in Sweden.BMC cardiovascular disorders · 2019Article
- Incidence and risk factors for recurrent cardiovascular disease in middle-eastern adults: a retrospective study.BMC cardiovascular disorders · 2019Article
- CD36 gene polymorphism rs1761667 (G > A) is associated with hypertension and coronary artery disease in an Iranian population.BMC cardiovascular disorders · 2019Observational
- The association between diabetes mellitus and reduction in myocardial glucose uptake: a population-basedBMC cardiovascular disorders · 2018Article
- Evaluation of health status and its predictor among university staff in Nigeria.BMC cardiovascular disorders · 2018Article
- Risk factors for prehypertension and their interactive effect: a cross- sectional survey in China.BMC cardiovascular disorders · 2018Article
- Is single-child family associated with cardio-metabolic risk factors: the CASPIAN-V study.BMC cardiovascular disorders · 2018Article
- Metformin restores electrophysiology of small conductance calcium-activated potassium channels in the atrium of GK diabetic rats.BMC cardiovascular disorders · 2018Article
- Is there a C-reactive protein value beyond which one should consider infection as the cause of acute heart failure?BMC cardiovascular disorders · 2018Article
- Homocysteine is a bystander for ST-segment elevation myocardial infarction: a case-control study.BMC cardiovascular disorders · 2018Article
- Independent association of resting energy expenditure with blood pressure: confirmation in populations of the African diaspora.BMC cardiovascular disorders · 2018Article
- Nutrition in primary and secondary prevention of cardiovascular risk in the continental and Mediterranean regions of Croatia.BMC cardiovascular disorders · 2017Observational
- PR interval prolongation in coronary patients or risk equivalent: excess risk of ischemic stroke and vascular pathophysiological insights.BMC cardiovascular disorders · 2017Article
- Cardiac tissue oxidative stress and inflammation after vitamin D administrations in high fat- diet induced obese rats.BMC cardiovascular disorders · 2017Article
- Regional and hospital variations in the extent of decline in the proportion of percutaneous coronary interventions performed for nonacute indications - a nationwide population-based study.BMC cardiovascular disorders · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 6 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background. A large number of clinical and laboratory markers have been appraised to predict prognosis in patients with stable angina, but uncertainty remains regarding which variables are the best predictors of prognosis. Therefore, we performed a meta-analysis of studies in patients with stable angina to assess which variables predict prognosis. Methods. MEDLINE and PubMed were searched for eligible studies published up to 2015, reporting multivariate predictors of major adverse cardiac events (MACE, a composite endpoint of death, myocardial infarction, and revascularization) in patients with stable angina. Study features, patient characteristics, and prevalence and predictors of such events were abstracted and pooled with random-effect methods (95% CIs). Major adverse cardiovascular event (MACE) was the primary endpoint. Results. 42 studies (104,559 patients) were included. After a median follow-up of 57 months, cardiovascular events occurred in 7.8% of patients with MI in 6.2% of patients and need for repeat revascularization (both surgical and percutaneous) in 19.5% of patients. Male sex, reduced EF, diabetes, prior MI, and high C-reactive protein were the most powerful predictors of cardiovascular events. Conclusions. We show that simple and low-cost clinical features may help clinicians in identifying the most appropriate diagnostic and therapeutic approaches within the broad range of outpatients presenting with stable coronary artery disease.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.